Sumitomo Pharma ¥102.1 billion stock offering
We advised the joint lead managers and joint bookrunners on the offering
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
Grayscale Hyperliquid Staking ETF launches on Nasdaq
We advised Grayscale on the Nasdaq listing and concurrent HYPE investment
Granite $600 million debut high-yield senior notes offering
We represented the initial purchasers on the notes offering
Peabody Energy $250 million convertible senior notes offering
We advised the initial purchasers on the offering
Roche acquisition of SAGA Diagnostics
We advised Roche on the transaction
Firefly Aerospace $576 million follow-on offering
We advised the underwriters of the offering
Sompo Holdings $1.3 billion senior notes offering
We advised the joint lead managers on the offering
Kennedy-Wilson $1.8 billion senior notes offering
We advised the initial purchasers on the high-yield notes offering
Xylem $1 billion senior notes offering
We advised the joint book-running managers
BioMar Group DKK 3.1 billion IPO
We advised BioMar on its IPO